Encouraging Research Shows New Cholesterol Busters Safe, Effective

Encouraging Research Shows New Cholesterol Busters Safe, Effective

For those who don't tolerate or benefit from statins, proof is building for a new class of drugs designed to reduce cholesterol.

The subject of cholesterol is dominating the headlines. Whether it’s about the drugs used to reduce high cholesterol levels or who should be treated, the topic is one that both healthcare professionals and their patients are actively discussing.

Continue Reading

Featured Articles

  • Remote ICD Monitoring Boosts Follow-up Compliance

    Your Heart and Other Conditions

    Remote ICD Monitoring Boosts Follow-up Compliance

    A Cleveland Clinic study suggests that new technology is making cardiac device use more coveneient and effective for patients.

    Individuals with implantable cardioverter defibrillators (ICDs) are more likely to follow up with their doctors and adhere strictly to their treatment plans if the patients can transmit device data remotely rather than having to make more in-person visits. That’s according to...

    Continue Reading

  • Study Questions the Concept Of “Healthy but Obese”

    Your Heart and Other Conditions

    Study Questions the Concept Of “Healthy but Obese”

    Evidence suggests that obesity may be contributing to atherosclerosis, even if other cardiovascular health indications appear normal.

    You may have heard the concept of “fat but fit,” which suggests that overweight or obese people can be considered in good cardiovascular health if they don’t have heart risk factors such as high blood pressure and diabetes.

    Continue Reading

  • FDA Says Fewer People Should Take Daily Aspirin

    Your Heart and Other Conditions

    FDA Says Fewer People Should Take Daily Aspirin

    Bleeding risks may outweigh the preventive benefits for those without heart disease.

    Taking a daily aspirin to help prevent a heart attack has been standard advice for just about anybody considered at risk for heart disease. But recently the U.S. Food and Drug Administration (FDA) issued a recommendation that essentially says daily aspirin therapy is only for...

    Continue Reading

  • AFib Patients Face Higher Risks with Antiplatelet Therapy

    Arrythmia

    AFib Patients Face Higher Risks with Antiplatelet Therapy

    You may be at a higher risk for bleeding if you add antiplatelet drugs to anticoagulant therapy.

    Atrial fibrillation (AFib) is usually treated with anticoagulant medications such as warfarin (Coumadin). AFib is the uncoordinated beating of the heart’s upper chambers (atria), which allows blood to pool in the heart. The result can be a blood clot that could leave the heart...

    Continue Reading